E-LIB Suche - Ergebnisse für: Hayoz, S.

1

155P Outcomes in patients with resectable stage III NSCLC w..:

Almeida, S. Cardoso ; Schaer, S. ; Hayoz, S....
ESMO Open. 9 (2024) - p. 102910 , 2024

Link: https://doi.org/10.1016/..

2

Neoadjuvant treatment does not influence PD-L1 expression i..:

König, D. ; Savic Prince, S. ; Hayoz, S....
ESMO Open. 8 (2023) 4 - p. 101595 , 2023

Link: https://doi.org/10.1016/..

3

188P SAKK 16/14: Immune profiling of pre-operative biopsies..:

Rothschild, S.I. ; Sobottka-Brillout, A.B. ; Tochtermann, G....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S142 , 2023

Link: https://doi.org/10.1016/..

4

SAKK 38/19: ASSESSING A CTDNA AND PET‐ORIENTED THERAPY IN P..:

Stathis, A. ; Hitz, F. ; Schär, S....
Hematological Oncology. 41 (2023) S2 - p. 165-166 , 2023

Link: https://doi.org/10.1002/..

5

Surgical safety and quality of radical cystectomy and pelvi..:

Afferi, L. ; Spahn, M. ; Hayoz, S....
European Urology. 83 (2023) - p. S230-S231 , 2023

Link: https://doi.org/10.1016/..

6

SAKK 35/14 RANDOMIZED TRIAL OF RITUXIMAB WITH OR WITHOUT IB..:

Østenstad, B. ; Pirosa, M. C. ; Schär, S....
Hematological Oncology. 41 (2023) S2 - p. 117-119 , 2023

Link: https://doi.org/10.1002/..

7

Long-term outcomes of operable stage III NSCLC in the pre-i..:

König, D. ; Schär, S. ; Vuong, D....
ESMO Open. 7 (2022) 2 - p. 100455 , 2022

Link: https://doi.org/10.1016/..

8

Long-term benefit of lurbinectedin as palliative chemothera..:

Mark, M. ; Rusakiewicz, S. ; Früh, M....
ESMO Open. 7 (2022) 3 - p. 100446 , 2022

Link: https://doi.org/10.1016/..

9

Prognostic and Predictive Performance of a 24-Gene Post-Ope..:

Pra, A. Dal ; Zwahlen, D.R. ; Liu, V.Y....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. S37-S38 , 2022

Link: https://doi.org/10.1016/..

10

Corrigendum to 'Long-term outcomes of operable stage III NS..:

König, D. ; Schär, S. ; Vuong, D....
ESMO Open. 7 (2022) 3 - p. 100494 , 2022

Link: https://doi.org/10.1016/..

11

Validation of the Decipher genomic classifier in patients r..:

Dal Pra, A. ; Ghadjar, P. ; Hayoz, S....
Annals of Oncology. 33 (2022) 9 - p. 950-958 , 2022

Link: https://doi.org/10.1016/..

12

EP16.01-018 SAKK 16/14 -Peripheral Immune Cell Populations ..:

Schmid, D. ; Trueb, M. ; Herzig, P....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S562-S563 , 2022

Link: https://doi.org/10.1016/..

13

OC-0949 Improved sparing of liver and lung tissue: DIBH for..:

Pace, R. ; Boucas da Silva, R.T. ; Adam, L.E.J....
Radiotherapy and Oncology. 170 (2022) - p. S841-S842 , 2022

Link: https://doi.org/10.1016/..

14

MA12.04 SAKK 16/14: CD8 T Cell Positioning Correlates with ..:

Sobottka, B. ; Tochtermann, G. ; Trueb, M....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S85-S86 , 2022

Link: https://doi.org/10.1016/..

15

INTEGRATION OF BASELINE METABOLIC PARAMETERS AND MUTATIONAL..:

Genta, S ; Ghilardi, G ; Cascione, L...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..